Skip to content
Menu

ImmunityBio, Inc. IBRX

Full chart Compare
Set alert

Price alert · IBRX

All alert types
6.57 USD -0.13 (-1.94%)

Regular-session close

6.50 -0.07 -1.07%

After hours · Nov 19, 7:58 PM ET

6.41 Day range 6.83
1.95 52-week range 12.43
YTD
+231.82%
1 year
+207.01%

IBRX free cash flow history

Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.

-309,188,000 USD

FY 2025 · Period ended

Coverage: complete. Values in USD; not inflation adjusted.

Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.

Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.

Scroll the table to see all values →

Free cash flow · annual · USD
Fiscal periodPeriod endFree cash flowYoY changeYoY %
FY 20252025-12-31-309,188,00088,936,000Not meaningful
FY 20242024-12-31-398,124,000-783,000Not meaningful
FY 20232023-12-31-397,341,00018,330,000Not meaningful
FY 20222022-12-31-415,671,000-128,187,000Not meaningful
FY 20212021-12-31-287,484,000-114,091,000Not meaningful
FY 20202020-12-31-173,393,000-17,197,000Not meaningful
FY 20192019-12-31-156,196,000-80,125,000Not meaningful
FY 20182018-12-31-76,071,0007,524,000Not meaningful
FY 20172017-12-31-83,595,000-38,442,000Not meaningful
FY 20162016-12-31-45,153,000-17,607,000Not meaningful
FY 20152015-12-31-27,546,000-21,893,000Not meaningful
FY 20142014-12-31-5,653,000-4,982,000Not meaningful
FY 20132013-12-31-671,000Not availableNot available

Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.

Company-reported financial statements. Retrieved 2026-08-07T06:02:12.000Z. Retrieval time is not a report date.

Open full statements

Use Add to watchlist above to save this stock.